28 December, 2015
The Court of Appeals of the Federal Circuit, in respect of a process patent for testing a drug, has held that infringement only occurs under 35 U.S.C. § 271(g), as a result of “making” a product, and does not extend to testing to determine whether an already synthesized drug substance possesses existing qualities. Section 271(g)...
© Copyright 1985-2017 Lakshmikumaran & Sridharan, All Rights Reserved.